Inventor
LIU YI-TSUNG
31 patents
⚠️ This page may combine multiple inventors who share the name “LIU YI-TSUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
26 patentsUS6800434B2Oct 5, 2004
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP89 citations97
US6440974B2Aug 27, 2002
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP53 citations96
US6228865B1May 8, 2001
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP61 citations96
US5661151AAug 26, 1997
Tetrahydrofuran antifungals
SCHERING CORP69 citations96
US6071907AJun 6, 2000
Tricyclic compounds useful as FPT inhibitors
SCHERING CORP21 citations93
US5714490AFeb 3, 1998
Tetrahydrofuran antifungals
SCHERING CORP37 citations93
US5693626ADec 2, 1997
Tetrahydrofuran antifungals
SCHERING CORP24 citations93
US6894072B2May 17, 2005
Compounds as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP59 citations92
US5403937AApr 4, 1995
Process for preparing intermediates for the synthesis of antifungal agents
SCHERING CORP21 citations92
US5710154AJan 20, 1998
Tetrahydrofuran antifungals
SCHERING CORP13 citations74
US5703236ADec 30, 1997
Tetrahydrofuran antifungals
SCHERING CORP11 citations74
US5703079ADec 30, 1997
Tetrahydrofuran antifungals
SCHERING CORP16 citations74
US4436729AMar 13, 1984
23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use
SCHERING CORP9 citations74
US4279896AJul 21, 1981
Novel 20-imino macrolide antibacterial agents
SCHERING CORP14 citations74
US4366309ADec 28, 1982
Derivatives of antibiotic AR-5 components
SCHERING CORP9 citations70
US7138396B2Nov 21, 2006
17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP3 citations62
US6903102B2Jun 7, 2005
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP3 citations62
US4431654AFeb 14, 1984
6-(Hydroxyethyl)-2-[(heterocyclyl or aryl)thioalkylthio]-penem-3-carboxylates
SCHERING CORP3 citations62
US4373095AFeb 8, 1983
Macrolide antibacterial AR-5 components
SCHERING CORP3 citations62
US4617300AOct 14, 1986
2(N-heterocyclyl) penems
SCHERING CORP2 citations60
US4435388AMar 6, 1984
Tylosin 20-imino-20-deoxo-4"-acyl derivatives, pharmaceutical compositions and method of use
SCHERING CORP6 citations57
US7595299B2Sep 29, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP0 citations51
US7485645B2Feb 3, 2009
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP1 citations51
US7432268B2Oct 7, 2008
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP1 citations51
US7271175B2Sep 18, 2007
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP1 citations51
US7053091B2May 30, 2006
17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SCHERING CORP0 citations51
DENDREON CORP
3 patentsUS7012066B2Mar 14, 2006
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP176 citations98
US7244721B2Jul 17, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP80 citations97
US7169760B2Jan 30, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP88 citations97